| Cat. No. |
Product Name |
Information |
| PC-45519 |
OSU-T315
ILK inhibitor
|
OSU-T315 is a potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 uM. |
| PC-45501 |
CWHM-12
αV integrins inhibitor
|
CWHM-12 is a potent RGD peptidomimetic inhibitor of αv integrins with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8. |
| PC-42179 |
GLPG0187
Integrin inhibitor
|
GLPG0187 (GLPG 0187) is a highly potent, broad spectrum integrin receptor antagonist with IC50 of 1-10 nM for αvβ1, αvβ3, αvβ5, αvβ6, αvβ8 and α5β1. |
| PC-47465 |
Cyclo(RGDfK)
αvβ3 integrin inhibitor
|
Cyclo(RGDfK) is a RGD pipetide, potent and selective αvβ3 integrin inhibitor with Kd of 41.7 nM. |
| PC-23193 |
Carotegrast
α4 integrin inhibitor
|
Carotegrast (HCA2969) is a novel potent, selective, oraaly available alpha 4 integrin antagonist. |
| PC-21536 |
ATN-161 TFA salt
Integrin inhibitor
|
ATN-161 TFA salt (Ac-PHSCN-NH2) is a small peptide inhibitor of integrin alpha5 beta1 (α5β1) and alphavbeta3 (αvβ3) with binding Kd of 1.0 and 0.6 uM, respectively, inhibits breast cancer growth and metastasis. |
| PC-21535 |
ATN-161
Integrin inhibitor
|
ATN-161 (Ac-PHSCN-NH2) is a small peptide inhibitor of integrin alpha5 beta1 (α5β1) and alphavbeta3 (αvβ3) with binding Kd of 1.0 and 0.6 uM, respectively, inhibits breast cancer growth and metastasis. |
| PC-49780 |
6-B345TTQ
Paxillin inhibitor
|
6-B345TTQ is a small molecule inhibitor of the α4 integrin-paxillin interaction, impairs the interaction of native paxillin with α4 integrin, decreases α4-mediated cell migration. |
| PC-73164 |
Cilengitide
Integrin inhibitor
|
Cilengitide (EMD 121974) is a potent, selective, cyclic Arg-Gly-Asp peptide inhibitor of integrins αvβ3 and αvβ5 with IC50 4.1 and 70 nM, respectively. |
